able from patient to patient. In univariate analysis, patients who had an abnormal response had a higher increase in both peak (89±30 mm Hg) (p=0.041) and mean (55±20 mm Hg) (p=0.043) transvalvular pressure gradients. At rest both E/A ratio (1,12±0,5) (p:0.044) and E/Ea ratio (23±11) (p:0.027) were higher in the symptomatic group. During exercise E/Ea ratio and the variation of E/Ea were significantly higher in the symptomatic group. By multivariate logistic regression analysis, 2 independent predictors of an abnormal response to exercise were a higher increase of mean transaortic pressure gradient (p=0.0075) and of E/Ea ratio (p=0.0232) during exercise. Conclusions: Increases of both mean aortic pressure gradient and of the E/ Ea ratio are predictive of an abnormal response to exercise in patients with severe asymptomatic aortic stenosis.
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Identifying valvular & structural heart disease using brain natiuretic peptide: a three assay comparison 
Chester, United Kingdom
Objective: BNP has a widely developing role in predicting cardiac disease other than just LV dysfunction. We evaluate the use of three separate serum Brain Natiuretic Peptide (BNP) assays combined with other demographic and clinical data to predict significant valvular heart disease and other structural abnormalities in a cohort of patients with suspected heart failure. Design: Prospective, single blinded cohort study of 95 patients referred by General Practitioners for open access Echocardiography. The echocardiographer was blinded to the serum BNP levels. Setting: A UK District General Hospital. Variables: Age, sex, British society of echocardiography (BSE) standard adult echocardiogram, creatinine, chest x-ray (CXR), ECG, cardiovascular risk factors, symptoms and signs, medication, simultaneous Roche® E170 NT proBNP (R-pBNP), Bayer® Centaur BNP (BC-BNP) &Biosite® Triage BNP (BT-BNP) levels. Results: A total of 93 echocardiographs were of diagnostic quality. Including ventricular dilatation and dysfunction, or valve disease or ventricular hypertrophy classed as moderate or severe, a total of 19 patients had abnormal echocardiographs (20%). The R-pBNP assay had the highest negative predictive value at 95%, but lacked specificity when compared with the other assays (R-pBNP: sensitivity 89%, specificity 55%, positive predictive value (PPV) 34%, negative predictive value (NPV) 95%; BC-BNP: sensitivity 63%, specificity 85%, PPV 52%, NPV 90%; BT-BNP: sensitivity 58%, specificity 84%, PPV 48%, NPV 89%). Conclusions: As well as predicting absence of LVSD, a negative BNP appears to be a reliable predictor of a structurally normal heart. Used alone to predict a normal echocardiogram, BNP can offer a substantial reduction in departmental workload (R-pBNP 45.3%, BC-BNP&BT-BNP 73.7%).
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Prevalence of echocardiographic valvular regurgitation in healthy children Although clinically significant heart valvular insufficiency is rare in childhood, the use of sensitive modern echocardiographic systems could result in an increased prevalence of silent valvular regurgitation among otherwise healthy children. Aim: To evaluate the prevalence of echocardiographic valvular regurgitation (VR) among healthy school age children of Mediterranean origin. Patients-Methods: A group of 125 consecutive children, (62 boys, 63 girls, median age 8.8 yrs, range 8.2 to 10.2 yrs) participating to the initial phase of Cretan Pediatric Cardiology Survey (CPCS), were enrolled to the study. CPCS is a large scale population based study of the cardiovascular health of school age children of Cretan origin, approved by the Greek Ministry of Education. Participants undergo a detailed evaluation including cardiac auscultation, ECG and echocardiography (using a Vivid 3 Expert, GE System and age appropriate transducers). Echocardiographic valvular incompetence, was considered as insignificant in the presence of trace (at the level of valve leaflets, detected by colour Doppler) or mild (beyond the level of valve leaflets, detected additionally by PW Doppler) regurgitation. Cases of more severe valvular regurgitation, or prolapse (in cases of MVR) and/or abnormal auscultatory findings, were considered as significant. Results: Pulmonary VR was present in 88% (trace 85%, mild 3%), tricuspid VR in 72% (trace 66%, mild 6%), mitral VR in 45.6% (trace 44%, mild 1.6%) and aortic VR in 24% (trace 20%, mild 4%) of children. Valvular regurgitation was either isolated (18%) or combined (70%) (involving two (28%), three (30%) or four valves (12%)). Mitral valve prolapse and bicuspid AoV were detected in 4.8% and 8% of children; their presence was associated with an increased likelihood for valvular regurgitation (O.R=5.6 and O.R=23.6 for AVR and MVR respectively, p<0.005). Clinical auscultation alone failed to detect children with mild echocardiographic valvular regurgitation. Conclusions: Silent valvular regurgitation, detected during routine echocardiographic evaluation, is very common among healthy children. In the presence of a morphological normal aortic and mitral valve it should be interpreted as a normal finding. 
Hospital de Galdakao, Vizcaya, Spain
Restrictive valvular heart disease has been reported in patients with Parkinson disease treated with pergolide. However, few data are avaible on actual frecuency, severity and dose-dependency of pergolide-induced disease. Aim: To evaluate in a double blind and prospective study, the presence of valvular heart disease in patients treated with pergolide versus patients with Parkinson disease age-sex matched never treated with pergolide (controls). Patients and methods: 26 patients treated with pergolide and 26 never treated were evaluated by echocardiography. Systolic and diastolic function, valvular heart disease and systolic pulmonary artery pressures (SPAP) were determined. Results: Mean cumulative doses of pergolide was 4401 mg y daily doses was 2.19±1.24 mg/day. Mean time of treatment was 64±35 months. Some of the results are in the table. Mitral and aortic mild esclerodegenerative changes without any repercussion were frequent in both groups as is expected in this older population. In the pergolide group, important restrictive valvular heart disease was present in two patients (2/26) with significant mitral and tricuspid regurgitation and none in the control group (in this non pergolide group, significant regurgitations were related to degenerative valvular heart disease, no restrictive). No association was found between doses and time of treatment and the presence of restrictive valvular disease. Conclusion: In our patients with Parkinson´s disease treated with pergolide doses <5 mg/d, pergolide-induced restrictive valvular heart disease is present in 8% of patients, a lower frequency than previously reported. Objective: Annular dynamics play an important role in the valvular and ventricular function. We evaluate the effects of pericardial annuloplasty rings on mitral annulus dynamics and left-ventricular (LV) function after mitral-valve repair. Material and methods: 100 consecutive patients were prospectively enrolled. All patients had myxomatous mitral valve with severe regurgitation and underwent identical surgical mitral-valve reconstruction. All patients underwent mitral annuloplasty with an autologous pericardial ring and other method of repair depends on involved segments. Post-operative LV systolic indices have been assessed by two-dimensional echocardiography at rest and during exercise. Mitral annular motion has been examined by mitral annulus systolic excursion (MASE). Mean and peak trans-mitral flow velocities (TMFV) and mitral valve area (MVA) have been also evaluated by continuous-wave Doppler.
Results:
The mean follow-up did not differ between the groups, those being 24±6 months in (range12-35 months). Post-operative echocardiographic study did not show significant mitral regurgitation at rest or at peak exercise in any patient. There was significant increased in TMFV (from 1.14±0.20 to 1.68±0.22 m/s, t=-8, p<0.0001). Recruitment of LVEF reserve during exercise was observed (from 55.5±7 to 65.4±5%, t=-3.95, p<0.005). Significant increased MASE at all the studied longitudinal segments at rest and during exercise was observed in all patients. No calcifications have been observed on pericardial rings.
Conclusions:
The autologous pericardium for annuloplasty in mitral valve has excellent mitral annulus dynamics and preserves LV function during stress conditions. Effective annular remodelling with the autologous pericardium is shown, with no echocardiographic sign of degeneration. Further studies are required to compare biological versus flexible prosthetic rings in mitral valve repair. Aortic sclerosis (AS) is a marker of increased risk for cardiovascular events. AS incidence increases with age and in specific clinical settings, and it is thought to represent a marker of atherosclerosis. Its prevalence and determinants, however, in patients with both coronary artery disease (CAD) and peripheral artery disease (PAD) are not known. Purpose: To assess the prevalence and the determinants of AS in patients with CAD and PAD. Methods: Patients referred for echocardiography for suspected cardiac disease were prospectively enrolled in the study. Aortic sclerosis was defined by echocardiography as focal areas of increased echogenecity on aortic cusps not inducing stenosis, i.e. maximal aortic velocity < or =2.5 m/s. History of CAD, PAD, hypertension, dyslipidemia, diabetes, and smoke were assessed in each patient. 215 patients (age 69±9 years, 167 men) were divided into four age and sex matched groups: 63 had neither history of CAD nor PAD (normal), 71 had CAD, 24 had PAD, and in the remaining 57 there was history of both CAD and PAD. Results: AS was found in 66 patients; patients with AS were older than patients without (71±7 vs 64±9 years, p<0.001). AS prevalence increased significantly in patients with both CAD and PAD (Figure) . By logistic regression analysis, determinants of AS were found to be age and coexistence of CAD and PAD (p<0.001).
